AOD9604 vs HGH Fragment 176-191: What’s the Difference?
The main difference between AOD9604 and HGH Fragment 176-191 is mechanism: AOD9604 is studied for lipolysis without gh side-effects — Modified C-terminus fragment of HGH. HGH Fragment 176-191 is studied for fat-loss fragment of human growth hormone — Isolated fat-burning portion of HGH.
Modified C-terminal GH fragment vs base 176-191.
Key differences between AOD9604 and HGH Fragment 176-191
- •Mechanism: AOD9604 — Modified C-terminus fragment of HGH. HGH Fragment 176-191 — Isolated fat-burning portion of HGH.
- •Primary research focus: AOD9604 is studied for lipolysis without gh side-effects; HGH Fragment 176-191 is studied for fat-loss fragment of human growth hormone.
- •Depth of human research: AOD9604 — Strong; HGH Fragment 176-191 — Moderate.
- •Typical study cadence cited in the literature: AOD9604 — Daily, typically AM fasted; HGH Fragment 176-191 — Daily AM fasted, or split 2–3× daily.
| Attribute | AOD9604 Anti-Obesity Drug 9604 | HGH Fragment 176-191 AOD analog, HGH Frag |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Lipolysis without GH side-effects | Fat-loss fragment of human growth hormone |
| Mechanism of action | Modified C-terminus fragment of HGH. Stimulates lipolysis without affecting blood sugar or IGF-1. | Isolated fat-burning portion of HGH. No IGF-1 elevation, no mass gain, no insulin resistance. |
| Human research | Strong | Moderate |
| Animal research | Strong | Moderate |
| Mechanistic research | Established | Established |
| Study cadence cited | Daily, typically AM fasted | Daily AM fasted, or split 2–3× daily |
| In plain English | AOD9604 isolates the fat-burning effect of growth hormone without the muscle-building or blood-sugar effects. | It is the 'fat-loss-only' slice of growth hormone, studied without the blood sugar and IGF-1 effects of full HGH. |
| How it works | Stimulates lipolysis and inhibits lipogenesis without significant effect on IGF-1, insulin sensitivity, or glucose. | Believed to activate beta-3 adrenergic receptors on fat cells and stimulate lipolysis while sparing growth-related signaling. |
| Researchers study | Obesity, body composition, and osteoarthritis (intra-articular use). | Lipolysis, body composition research, comparison with AOD9604, metabolic rate. |
| Internet discussion | Discussed for targeted fat loss. | Discussed in fat-loss and recomp circles alongside GLP-1s and AOD9604. |
Mechanism and research evidence, side by side
How AOD9604 and HGH Fragment 176-191 differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
AOD9604
Modified C-terminus fragment of HGH. Stimulates lipolysis without affecting blood sugar or IGF-1.
- Incretin and appetite-regulating receptors
- Slowed gastric emptying and altered satiety signalling
- Energy-balance and glycaemic research endpoints
- Human research
- Strong
- Animal research
- Strong
- Mechanistic research
- Established
Fat loss without affecting blood sugar or growth hormone axis
HGH Fragment 176-191
Isolated fat-burning portion of HGH. No IGF-1 elevation, no mass gain, no insulin resistance.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Targeted fat burning without HGH-related side effects
AOD9604
Lipolysis without GH side-effects
AOD9604 isolates the fat-burning effect of growth hormone without the muscle-building or blood-sugar effects.
Stimulates lipolysis and inhibits lipogenesis without significant effect on IGF-1, insulin sensitivity, or glucose.
Obesity, body composition, and osteoarthritis (intra-articular use).
Discussed for targeted fat loss.
AOD9604 is an hGH fragment researched for fat-burning effects without anabolic side effects.
HGH Fragment 176-191
Fat-loss fragment of human growth hormone
It is the 'fat-loss-only' slice of growth hormone, studied without the blood sugar and IGF-1 effects of full HGH.
Believed to activate beta-3 adrenergic receptors on fat cells and stimulate lipolysis while sparing growth-related signaling.
Lipolysis, body composition research, comparison with AOD9604, metabolic rate.
Discussed in fat-loss and recomp circles alongside GLP-1s and AOD9604.
HGH Fragment 176-191 is the C-terminal fat-loss fragment of human growth hormone, studied for lipolysis without glucose or IGF-1 effects.